Valuing height: diagnosis, valuation and the case of idiopathic short stature
This paper proposes a ‘valuographic’ approach to diagnosis, exploring how values and valuation practices are implicated in the contested diagnostic category of idiopathic short stature (ISS). ISS describes children who are ‘abnormally’ short but do not have any other detectable pathology. In the USA...
第一著者: | Morrison, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
John Wiley and Sons, Ltd.
2018
|
類似資料
-
Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment
著者:: Hyun Wook Chae, 等
出版事項: (2022-09-01) -
O14: A polygenic score for height to distinguish between children with idiopathic and pathologic short stature
著者:: John Shelley, 等
出版事項: (2024-01-01) -
Association between uric acid and height during growth hormone therapy in children with idiopathic short stature
著者:: Jong Seo Yoon, 等
出版事項: (2022-12-01) -
Evaluation of craniofacial morphology in short-statured children: growth hormone deficiency versus idiopathic short stature
著者:: Ki Bong Kim, 等
出版事項: (2021-01-01) -
Short Stature Diagnosis and Referral
著者:: Mohamad Maghnie, 等
出版事項: (2018-01-01)